Literature DB >> 27512106

Precision medicine in idiopathic pulmonary fibrosis.

T M Maher1,2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27512106      PMCID: PMC5943832          DOI: 10.1093/qjmed/hcw117

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


× No keyword cloud information.
  20 in total

1.  The European IPF Network: towards better care for a dreadful disease.

Authors:  A Guenther
Journal:  Eur Respir J       Date:  2011-04       Impact factor: 16.671

2.  A new initiative on precision medicine.

Authors:  Francis S Collins; Harold Varmus
Journal:  N Engl J Med       Date:  2015-01-30       Impact factor: 91.245

3.  Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.

Authors:  Hector G Ortega; Steven W Yancey; Bhabita Mayer; Necdet B Gunsoy; Oliver N Keene; Eugene R Bleecker; Christopher E Brightling; Ian D Pavord
Journal:  Lancet Respir Med       Date:  2016-05-10       Impact factor: 30.700

4.  Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology.

Authors:  C Vancheri; M Failla; N Crimi; G Raghu
Journal:  Eur Respir J       Date:  2010-03       Impact factor: 16.671

5.  Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.

Authors:  Payal K Naik; Paul D Bozyk; J Kelley Bentley; Antonia P Popova; Carolyn M Birch; Carol A Wilke; Christopher D Fry; Eric S White; Thomas H Sisson; Nabihah Tayob; Barbara Carnemolla; Paola Orecchia; Kevin R Flaherty; Marc B Hershenson; Susan Murray; Fernando J Martinez; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-10-05       Impact factor: 5.464

6.  TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.

Authors:  Justin M Oldham; Shwu-Fan Ma; Fernando J Martinez; Kevin J Anstrom; Ganesh Raghu; David A Schwartz; Eleanor Valenzi; Leah Witt; Cathryn Lee; Rekha Vij; Yong Huang; Mary E Strek; Imre Noth
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

Review 7.  Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis.

Authors:  Robert Brownell; Naftali Kaminski; Prescott G Woodruff; Williamson Z Bradford; Luca Richeldi; Fernando J Martinez; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2016-06-01       Impact factor: 21.405

8.  Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.

Authors:  Daryle J DePianto; Sanjay Chandriani; Alexander R Abbas; Guiquan Jia; Elsa N N'Diaye; Patrick Caplazi; Steven E Kauder; Sabyasachi Biswas; Satyajit K Karnik; Connie Ha; Zora Modrusan; Michael A Matthay; Jasleen Kukreja; Harold R Collard; Jackson G Egen; Paul J Wolters; Joseph R Arron
Journal:  Thorax       Date:  2014-09-12       Impact factor: 9.139

Review 9.  Drug therapies in severe asthma - the era of stratified medicine.

Authors:  Kathy J Hetherington; Liam G Heaney
Journal:  Clin Med (Lond)       Date:  2015-10       Impact factor: 2.659

10.  Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.

Authors:  Tasha E Fingerlin; Elissa Murphy; Weiming Zhang; Anna L Peljto; Kevin K Brown; Mark P Steele; James E Loyd; Gregory P Cosgrove; David Lynch; Steve Groshong; Harold R Collard; Paul J Wolters; Williamson Z Bradford; Karl Kossen; Scott D Seiwert; Roland M du Bois; Christine Kim Garcia; Megan S Devine; Gunnar Gudmundsson; Helgi J Isaksson; Naftali Kaminski; Yingze Zhang; Kevin F Gibson; Lisa H Lancaster; Joy D Cogan; Wendi R Mason; Toby M Maher; Philip L Molyneaux; Athol U Wells; Miriam F Moffatt; Moises Selman; Annie Pardo; Dong Soon Kim; James D Crapo; Barry J Make; Elizabeth A Regan; Dinesha S Walek; Jerry J Daniel; Yoichiro Kamatani; Diana Zelenika; Keith Smith; David McKean; Brent S Pedersen; Janet Talbert; Raven N Kidd; Cheryl R Markin; Kenneth B Beckman; Mark Lathrop; Marvin I Schwarz; David A Schwartz
Journal:  Nat Genet       Date:  2013-04-14       Impact factor: 38.330

View more
  6 in total

1.  Update in Interstitial Lung Disease 2016.

Authors:  Athol U Wells; Toby M Maher
Journal:  Am J Respir Crit Care Med       Date:  2017-07-15       Impact factor: 21.405

2.  Is personalized medicine a realistic goal in idiopathic pulmonary fibrosis?

Authors:  Victor J Thannickal; Veena B Antony
Journal:  Expert Rev Respir Med       Date:  2018-04-19       Impact factor: 3.772

3.  CD71- Alveolar Macrophages in Idiopathic Pulmonary Fibrosis: A Look beyond the Borders of the Disease.

Authors:  Ermanno Puxeddu; Daniela Fraboni; Giuseppe Cillis; Francesco Cavalli; Francesco Buccisano; Paola Rogliani
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405

4.  Towards a global initiative for fibrosis treatment (GIFT).

Authors:  Maria Molina-Molina; Alvar Agusti; Bruno Crestani; David A Schwartz; Melanie Königshoff; Rachel C Chambers; Toby M Maher; Rosa Faner; Ana Lucia Mora; Mauricio Rojas; Katerina M Antoniou; Jacobo Sellares
Journal:  ERJ Open Res       Date:  2017-12-01

5.  The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study.

Authors:  L Plantier; A Smolinska; R Fijten; M Flamant; J Dallinga; J J Mercadier; D Pachen; M P d'Ortho; F J van Schooten; B Crestani; A W Boots
Journal:  Respir Res       Date:  2022-01-20

Review 6.  The role of precision medicine in interstitial lung disease.

Authors:  Toby M Maher; Anoop M Nambiar; Athol U Wells
Journal:  Eur Respir J       Date:  2022-02-03       Impact factor: 33.795

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.